WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...
Investing.com - KeyBanc reiterated its Overweight rating and $220.00 price target on Repligen (NASDAQ:RGEN) on Tuesday, highlighting the company’s differentiated filtration portfolio. Currently ...
WALTHAM, Mass., July 31, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced Novasign and Repligen have ...
Repligen said today it has acquired TangenX Technology from Novasep Holding for $39 million in a deal that adds to the bioprocessing company’s single-use technology offerings and broadens its ...
Repligen Corp. announced Friday an agreement to buy privately-held filtration company Spectrum Inc. for about $359 million. Under terms of the deal, Repligen will pay $120 million in cash and 6.154 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results